Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

VitaNova Life Sciences (YJGJ) Other Operating Expenses (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Other Operating Expenses for 5 consecutive years, with $42189.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses fell 20.59% year-over-year to $42189.0, compared with a TTM value of $172250.0 through Oct 2025, down 13.65%, and an annual FY2025 reading of $209274.0, up 145.26% over the prior year.
  • Other Operating Expenses was $42189.0 for Q4 2025 at VitaNova Life Sciences, up from $34928.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $85329.0 in Q2 2024 and bottomed at $34928.0 in Q3 2025.